151 Results

People

  1. Livingston
    Livingston
  2. Ragupathi
    Ragupathi
  3. Old
    Old
  4. Ritter
    Ritter
  5. Danishefsky
    Danishefsky
  6. Gnjatic
    Gnjatic
  7. Houghton
    Houghton
  8. Wolchok
    Wolchok
  9. Jungbluth
    Jungbluth
  10. Chapman
    Chapman

Groups

  1. Department of Medicine (69)
  2. Solid Tumor Oncology Division (56)
  3. Melanoma and Immunotherapeutics Service (50)
  4. Sloan Kettering Institute Faculty (46)
  5. Melanoma Disease Management Team (41)
  6. GSK Faculty (34)
  7. Sloan Kettering Institute Postdocs (32)
  8. Molecular Pharmacology and Chemistry Program Faculty (29)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  10. Immunology Program Faculty (21)
  1. "antibody response"
Formats
  1. Journal Article (145)
  2. Editorial (2)
  3. Conference Paper (1)
  4. Correspondence (1)
  5. Meeting Abstract (1)
  6. Review (1)
Groups
  1. Department of Medicine (69)
  2. Solid Tumor Oncology Division (56)
  3. Melanoma and Immunotherapeutics Service (50)
  4. Sloan Kettering Institute Faculty (46)
  5. Melanoma Disease Management Team (41)
  6. GSK Faculty (34)

More Groups

People
  1. Philip Livingston (43)
  2. Govindaswami Ragupathi (31)
  3. Lloyd Old (29)
  4. Gerd Ritter (25)
  5. Samuel Danishefsky (17)
  6. Sacha Gnjatic (16)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (1)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Clinical Cancer Research (18)
  2. Cancer Immunology, Immunotherapy (14)
  3. Proceedings of the National Academy of Sciences of the United States of America (12)
  4. International Journal of Cancer (8)
  5. Vaccine (7)
  6. Cancer Research (6)

More Publications

Publishers
  1. American Association for Cancer Research (25)
  2. Elsevier Inc. (17)
  3. Springer (16)
  4. National Academy of Sciences (12)
  5. John Wiley & Sons (10)
  6. Lippincott Williams & Wilkins (5)

More Publishers

Results (151)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines
    Journal Article

    Kim, S. K.; Ragupathi, G.; Musselli, C.; Choi, S. J.; Park, Y. S.; Livingston, P. O.
    Vaccine (1999)

    Fulltext@MSK | Save
  • Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Adluri, S.; Ungers, G.; Terry, K.; Kim, S.; Spassova, M.; Bornmann, W. G.; Fazzari, M.; Dantis, L.; more...
    Proceedings of the National Academy of Sciences of the United States of America (1999)

    Fulltext@MSK | Save
  • Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function
    Journal Article

    Wang, Z. Q.; Horowitz, H. W.; Orlikowsky, T.; Hahn, B. I.; Trejo, V.; Bapat, A. S.; Mittler, R. S.; Rayanade, R. J.; Young Yang, S.; Hoffmann, M. K.
    Journal of Infectious Diseases (1999)

    Fulltext@MSK | Save
  • Coupling and uncoupling of tumor immunity and autoimmunity
    Journal Article

    Bowne, W. B.; Srinivasan, R.; Wolchok, J. D.; Hawkins, W. G.; Blachere, N. E.; Dyall, R.; Lewis, J. J.; Houghton, A. N.
    Journal of Experimental Medicine (1999)

    Fulltext@MSK | Save
  • Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-GuĂ©rin
    Journal Article

    Grant, S. C.; Kris, M. G.; Houghton, A. N.; Chapman, P. B.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells
    Journal Article

    Ragupathi, G.; Howard, L.; Cappello, S.; Koganty, R. R.; Qiu, D.; Longenecker, B. M.; Reddish, M. A.; Lloyd, K. O.; Livingston, P. O.
    Cancer Immunology, Immunotherapy (1999)

    Fulltext@MSK | Save
  • Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: Detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal
    Journal Article

    Greenlee, J. E.; Dalmau, J.; Lyons, T.; Clawson, S.; Smith, R. H.; Pirch, H. R.
    Annals of Neurology (1999)

    Fulltext@MSK | Save
  • New paths in human cancer serology
    Journal Article

    Old, L. J.; Chen, Y. T.
    Journal of Experimental Medicine (1998)

    Fulltext@MSK | Save
  • Vaccines and other adjuvant therapies for melanoma
    Journal Article

    Wolchok, J. D.; Livingston, P. O.; Houghton, A. N.
    Hematology/Oncology Clinics of North America (1998)

    Fulltext@MSK | Save
  • Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis
    Journal Article

    Graus, Y. F.; Verschuuren, J. J.; Degenhardt, A.; van Breda Vriesman, P. J.; De Baets, M. H.; Posner, J. B.; Burton, D. R.; Dalmau, J.
    Journal of Neuroimmunology (1998)

    Fulltext@MSK | Save